Showing results (21-30 of 764) with videos related to
Sort By:
Pageof 77
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II studyBrian K Link, Peter Martin, Mark S Kaminski, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
New developments in the treatment of follicular lymphomaJohn P LeonardHematology. American Society of Hematology. Education Program|November 24, 2005
Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugatesJohn P LeonardClinical Lymphoma, Myeloma & Leukemia|December 31, 2013
Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative resultsJia Ruan, Stephanie A Gregory, Paul Christos, et al.Seminars in Hematology|April 3, 2008
Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphomaPeter Martin, Richard R Furman, Jia Ruan, et al.Journal of Palliative Medicine|October 22, 2019
Illness Understanding and Advance Care Planning in Patients with Advanced LymphomaKelly M Trevino, Sarah C Rutherford, Chrystal Marte, et al.Palliative & Supportive Care|June 17, 2022
Unmet mental health needs in patients with advanced B-cell lymphomasChrystal Marte, Login S George, Sarah C Rutherford, et al.Clinical Lymphoma & Myeloma|November 15, 2006
Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the dataBiree Andemariam, John P LeonardHematology. American Society of Hematology. Education Program|December 10, 2013
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOPLeandro Cerchietti, John P LeonardBiologics : Targets & Therapy|August 27, 2009
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphomaBiree Andemariam, John P LeonardPageof 77